Medifast MED EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medifast's EPS (diluted)?
- Medifast (MED) reported EPS (diluted) of -$0.19 in Q1 2026.
- How has Medifast's EPS (diluted) changed year-over-year?
- Medifast's EPS (diluted) decreased by 171.4% year-over-year, from -$0.07 to -$0.19.
- What is the long-term trend for Medifast's EPS (diluted)?
- Over 4 years (2021 to 2025), Medifast's EPS (diluted) has grown at a -40.8% compound annual growth rate (CAGR), from $13.89 to -$1.71.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.